Obesity is the illness in which body gain lot of fat, and may have a negative impact on health. It can be manage by changing the lifestyle and manage it effectively. As with all other chronic condition, obesity management also required highly motivated patient and a committed team of healthcare professional. Both the patient and the healthcare professional starts with comprehensive lifestyle management, and focus on goal setting, stimulus control, nonfood rewards, relapse prevention, and self-monitoring of caloric intake and physical activity. According to report of World Health Organization (WHO), 41 million children under the age of 5 were overweight or obese and 600 million adults were obese in 2014.
Pfizer Inc. (U.S.), Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), GlaxoSmithKline plc. (U.K), AstraZeneca plc (U.K), Herbalife Ltd. (U.S.), Apollo Endosurgery (U.S.), Ethicon, Inc. (U.S.) are some of the leading players at the cutting edge of the competition in the market of Obesity Management, globally.
Get a sample report at https://www.marketresearchfuture.com/sample_request/2690 .
Global Obesity Managements Market – Overview
The global obesity managements market is growing with a swift phase; mainly due to increase in patient population and research and development done by market players to fill the gap of market. According to World Health Organization (WHO), the worldwide prevalence of obesity nearly doubled between 1980 and 2008. According to country estimates for 2008, over 50% of both men and women in the WHO European Region were overweight, and roughly 23% of women and 20% of men were obese. It is the cause of many health problems, such as obesity, heart disease, and certain cancers. Obesity leads to short- and long-term health problems for mother and her child, if she is excess weight during pregnancy.
Companies are continuously engaged in research and development process along with well know research institute for developing the best treatment of obesity and leads the market. In 2015, researchers at the University of Liverpool, working with a global health care company, have helped introduce a new treatment for obesity. After conducting the research it was found that the treatment which is a once-daily injectable derivative of a metabolic hormone called GLP-1 normally used in the type 2 obesity treatment, has proved that it help non diabetic patients in weight loss. These development help company to provide the best option for the treatment and capture the maximum share of global market.
Companies are focusing on collaboration in order to introduce best treatment option in the market, in this regard, in 2015, Cold Spring Harbor Laboratory and GSK announced the collaboration for developing the treatment of obesity. Scientist of both CSHL and GSK, will focusing on drug development based on a novel approach to regulate the enzymatic activity of the phosphatase PTP1B. The goal of this collaboration is to find the best treatment option for managing the issues related with chronic disease obesity. These collaboration help GSK to minimize the gap of market along with others players of obesity management such as Pfizer Inc., Merck Sharp, F. Hoffmann-La Roche Ltd and many more.
Browse Complete Report at https://www.marketresearchfuture.com/reports/obesity-management-market-2690 .
The market of obesity managements is growing rapidly in Asia Pacific region, owing to poor diet, lack of physical activity, and unhealthy life balance. These are the factor which leads the obesity population in this region. Most of the countries of this region have common lifestyle and economic conditions, So the factor introduce above have common with in this region and leads the patient population. Government of developing countries within this region are more focusing towards new technology and advance treatment option, thus more research and development programs are initiated for the development of new drugs. These are the factors which are fuelling the growth of the market of obesity managements with the significant rates. These advance treatment will overcome the saturation that occurs during last few years. Countries like India and china are more focused market for global market players owing to huge patient population and growing purchasing power as compare to other countries in this region. The market of obesity management is much higher in the Americas region attribute to high presence of obesity population along with developed treatment option. According to CDC, 37.9% of adults over 20 years were suffering with the obesity between 2013 and 2014 and 70.7% of adults aged 20 years and over were suffering with overweight, including obesity. These stats show the opportunity of market players within the Americas region.
Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: akash.anand@marketresearchfuture.com
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/obesity-management-market-2690